Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 161

Similar articles for PubMed (Select 6255005)

1.

Effect of estrogen on calcium absorption and serum vitamin D metabolites in postmenopausal osteoporosis.

Gallagher JC, Riggs BL, DeLuca HF.

J Clin Endocrinol Metab. 1980 Dec;51(6):1359-64.

PMID:
6255005
2.

Intestinal calcium absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients: effect of age and dietary calcium.

Gallagher JC, Riggs BL, Eisman J, Hamstra A, Arnaud SB, DeLuca HF.

J Clin Invest. 1979 Sep;64(3):729-36.

3.

Ability of 25-hydroxyvitamin D3 therapy to augment serum 1,25- and 24,25-dihydroxyvitamin D in postmenopausal osteoporosis.

Lawoyin S, Zerwekh JE, Glass K, Pak CY.

J Clin Endocrinol Metab. 1980 Mar;50(3):593-6.

PMID:
6965678
4.

Main endocrine modulators of vitamin D hydroxylases in human pathophysiology.

Caniggia A, Lorè F, di Cairano G, Nuti R.

J Steroid Biochem. 1987;27(4-6):815-24. Review.

PMID:
3320561
5.

Long term 25-hydroxyvitamin D3 therapy in postmenopausal osteoporosis: demonstration of responsive and nonresponsive subgroups.

Zerwekh JE, Sakhaee K, Glass K, Pak CY.

J Clin Endocrinol Metab. 1983 Feb;56(2):410-3.

PMID:
6600460
6.
7.
8.
9.

Oral 1,25-dihydroxyvitamin D administration in osteoporotic women: effects of estrogen therapy.

Cosman F, Nieves J, Shen V, Lindsay R.

J Bone Miner Res. 1995 Apr;10(4):594-600.

PMID:
7610930
10.

Early postmenopausal bone loss is prevented by estrogen and partially by 1alpha-OH-vitamin D3: therapeutic effects of estrogen and/or 1alpha-OH-vitamin D3.

Gorai I, Chaki O, Taguchi Y, Nakayama M, Osada H, Suzuki N, Katagiri N, Misu Y, Minaguchi H.

Calcif Tissue Int. 1999 Jul;65(1):16-22.

PMID:
10369728
11.

Influence of vitamin D on parathyroid function in the elderly.

Quesada JM, Coopmans W, Ruiz B, Aljama P, Jans I, Bouillon R.

J Clin Endocrinol Metab. 1992 Aug;75(2):494-501.

PMID:
1639950
12.

A syndrome of osteoporosis, increased serum immunoreactive parathyroid hormone, and inappropriately low serum 1,25-dihydroxyvitamin D.

Riggs BL, Gallagher JC, DeLuca HF, Edis AJ, Lambert PW, Arnaud CD.

Mayo Clin Proc. 1978 Nov;53(11):701-6.

PMID:
713601
13.
14.

Orthophosphate therapy decreases urinary calcium excretion and serum 1,25-dihydroxyvitamin D concentrations in idiopathic hypercalciuria.

Van Den Berg CJ, Kumar R, Wilson DM, Heath H 3rd, Smith LH.

J Clin Endocrinol Metab. 1980 Nov;51(5):998-1001.

PMID:
6893460
15.

Serum vitamin D metabolites in younger and elderly postmenopausal women.

Christiansen C, Rødbro P.

Calcif Tissue Int. 1984 Jan;36(1):19-24.

PMID:
6423232
16.
17.

Comparison of vitamin D metabolism in early healthy and late osteoporotic postmenopausal women.

Hartwell D, Riis BJ, Christiansen C.

Calcif Tissue Int. 1990 Dec;47(6):332-7.

PMID:
2292078
18.

Role of vitamin D, its metabolites, and analogs in the management of osteoporosis.

Bikle DD.

Rheum Dis Clin North Am. 1994 Aug;20(3):759-75. Review.

PMID:
7984788
19.

Effect of growth hormone administration: reciprocal changes in serum 1 alpha,25-dihydroxyvitamin D and intestinal calcium absorption.

Chipman JJ, Zerwekh J, Nicar M, Marks J, Pak CY.

J Clin Endocrinol Metab. 1980 Aug;51(2):321-4.

PMID:
6249837
20.

[Relationship between serum 1,25-dihydroxyvitamin D and bone loss in postmenopausal women].

Zhu G, Wang H, Xu P.

Zhonghua Yi Xue Za Zhi. 2001 Dec 10;81(23):1443-6. Chinese.

PMID:
11930618
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk